74 related articles for article (PubMed ID: 8208481)
1. Identification of human immunodeficiency virus type 2 in a New Zealand resident.
Shroeder BA; Bridle M; Croxson MC; Franklin R
N Z Med J; 1994 Jun; 107(979):217-9. PubMed ID: 8208481
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
[TBL] [Abstract][Full Text] [Related]
3. Introduction of human immunodeficiency virus 2 infection into South Korea.
Kim SS; Kim EY; Park KY; Suh SD; Park HK; Shin YO; Bae M; Lee JS
Acta Virol; 2000 Feb; 44(1):15-22. PubMed ID: 10989687
[TBL] [Abstract][Full Text] [Related]
4. Synthetic peptide assays to detect human immunodeficiency virus types 1 and 2 in seropositive individuals.
Smith RS; Parks E
Arch Pathol Lab Med; 1990 Mar; 114(3):254-8. PubMed ID: 2407213
[TBL] [Abstract][Full Text] [Related]
5. [Search for antibodies against human immunodeficiency virus type 2 (HIV-2) in a sample of parenteral drug addicts (IVDA)].
Ortiz de Lejarazu R; Eiros JM; Perlado del Campo E; Palenzuela MS; Reguera JI; Rodríguez-Torres A
Enferm Infecc Microbiol Clin; 1990 Jan; 8(1):48-51. PubMed ID: 2095905
[TBL] [Abstract][Full Text] [Related]
6. Predominance of HIV-1 among patients with AIDS and AIDS-related complex in Ghana.
Brandful JA; Ampofo WK; Apeagyei FA; Asare-Bediako K; Osei-Kwasi M
East Afr Med J; 1997 Jan; 74(1):17-20. PubMed ID: 9145571
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus-1 infection in spouses of seropositive individuals.
Nandi J; Banerjee K; Thakar M; Bhavalkar V; Rodrigues J
Natl Med J India; 1993; 6(4):156-9. PubMed ID: 8401191
[TBL] [Abstract][Full Text] [Related]
8. HIV-1: absence of infection in subjects with indeterminate western blot.
Migali E; Mariotti D; Lovari A; Tenani T; Imperiali P; Ozzola G
Allergol Immunopathol (Madr); 1993; 21(2):61-5. PubMed ID: 8337990
[TBL] [Abstract][Full Text] [Related]
9. Indeterminate human immunodeficiency virus western blot results in Iranian patients with discordant screening assay results.
Ravanshad M; Mahboudi F; Sabahi F; Bayanolhagh S
Saudi Med J; 2006 Aug; 27(8):1130-3. PubMed ID: 16883439
[TBL] [Abstract][Full Text] [Related]
10. [Evidence of infection by HIV-2 in Madrid (1991)].
Gutiérrez M; Soriano V; Oliván M; Lago M; Puente S; Baquero M; González-Lahoz JM
An Med Interna; 1992 Mar; 9(3):111-5. PubMed ID: 1567945
[TBL] [Abstract][Full Text] [Related]
11. Serological, virological, and polymerase chain reaction studies of HIV type 1 and HIV type 2 infections in Ghanaian patients with AIDS and AIDS-related complex.
Ayisi NK; Mensah M; Ishikawa K; Sata T
AIDS Res Hum Retroviruses; 1995 Feb; 11(2):319-21. PubMed ID: 7742046
[TBL] [Abstract][Full Text] [Related]
12. Testing for antibodies to human immunodeficiency virus type 2 in the United States.
O'Brien TR; George JR; Epstein JS; Holmberg SD; Schochetman G
MMWR Recomm Rep; 1992 Jul; 41(RR-12):1-9. PubMed ID: 1324395
[TBL] [Abstract][Full Text] [Related]
13. [Human immunodeficiency virus type 1, type 2 (HIV-1, HIV-2)].
Fujii T
Nihon Rinsho; 2010 Jun; 68 Suppl 6():473-7. PubMed ID: 20942107
[No Abstract] [Full Text] [Related]
14. Evaluation of infection with human immunodeficiency virus type 1 by using nonisotopic solution hybridization for detection of polymerase chain reaction-amplified proviral DNA.
Coutlée F; Saint-Antoine P; Olivier C; Voyer H; Kessous-Elbaz A; Berrada F; Bégin P; Giroux L; Viscidi R
J Clin Microbiol; 1991 Nov; 29(11):2461-7. PubMed ID: 1774250
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of human immunodeficiency virus type 1 (HIV-1) infections with HIV-2-cross-reacting antibody from mixed infections with HIV-1 and HIV-2 by serological absorption test.
Imai M; Hayashi T; Kondo M; Saito T; Ito A; Hayami M; Nishioka K
J Clin Microbiol; 1995 Jul; 33(7):1727-9. PubMed ID: 7665636
[TBL] [Abstract][Full Text] [Related]
16. Identification of infection of an Australian resident with the human immunodeficiency virus type 2 (HIV-2).
Downie JC; Dwyer DE; Kazazi F; Chew CB; Dowton DN; Randle C; Singh V; Dax EM; Cunningham AL
Med J Aust; 1992 Sep; 157(6):415-7. PubMed ID: 1447996
[TBL] [Abstract][Full Text] [Related]
17. Characterization of dual HIV-1 and HIV-2 serological profiles by polymerase chain reaction.
Léonard G; Chaput A; Courgnaud V; Sangaré A; Denis F; Brechot C
AIDS; 1993 Sep; 7(9):1185-9. PubMed ID: 8216974
[TBL] [Abstract][Full Text] [Related]
18. HIV-2 infection and HIV-1/HIV-2 dual reactivity in patients with and without AIDS-related symptoms in Gabon.
Tevi-Benissan C; Okome M; Makuwa M; Nkoume MN; Lansoud-Soukate J; Georges A; Georges-Courbot MC; Belec L
Emerg Infect Dis; 1998; 4(1):130-1. PubMed ID: 9452410
[No Abstract] [Full Text] [Related]
19. HIV-1 and HIV-2 dual infection: lack of HIV-2 provirus correlates with low CD4+ lymphocyte counts.
Sarr AD; Hamel DJ; Thior I; Kokkotou E; Sankalé JL; Marlink RG; Coll-Seck EM; Essex ME; Siby T; NDoye I; Mboup S; Kanki PJ
AIDS; 1998 Jan; 12(2):131-7. PubMed ID: 9468361
[TBL] [Abstract][Full Text] [Related]
20. Increasing prevalence of HIV-2 and dual HIV-1-2 infections among patients attending various outdoor patient departments in Mumbai (Bombay).
Kamat HA; Banker DD; Koppikar GV
Indian J Public Health; 1999; 43(2):85-6. PubMed ID: 11243075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
